While we were immersed in bowel cancer screening budget news last week, an exciting research trial was starting to spice up the media pages around the world.
Curcumin - a compound found in turmeric, a main ingredient in curry powder - has been found to be highly effective in fighting cancer cells in the laboratory, particularly colon cancer cells.
Curcumin seems to have strong antioxidant and anti-inflammatory properties which are thought to be at least part of the reason for its effectiveness, but lab tests found it also seems to increase the ability of chemotherapy to kill bowel cancer cells.
A small human trial is underway in Leicester, UK where its large Indian and Pakistani population have a 70 per cent lower incidence of bowel cancer than the rest of Britain.
In the trial, expected to take two years, patients with bowel cancer will be given curcumin with their chemotherapy to see whether exciting lab results will be repeated.